Clinical utility of endoscopic resection for the treatment of rectal neuroendocrine tumors: a retrospective cohort study

Clinical utility of endoscopic resection for the treatment of rectal neuroendocrine tumors: a retrospective cohort study - Utility of endoscopic resection for the treatment of rectal neuroendocrine tumors

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000043210

Enrollment

150

Registered

2021-02-10

Start date

2020-09-30

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rectal neuroendocrine neoplasm (NEN)

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with rectal NEN

Exclusion criteria

Exclusion criteria: 1. Patients < 20 year-old 2. Patients who are considered as inappropriate by doctors

Design outcomes

Primary

Measure	Time frame
Survival and recurrence rates	—

Secondary

Measure	Time frame
Complete resection rate, procedure time, complication rate (perforation, bleeding), complete resection rate by endoscopic submucosal dissection	—

Countries

Japan

Contacts

Public ContactYasuhiko Hamada

Mie University Hospital Department of Gastroenterology and Hepatology

y-hamada@clin.medic.mie-u.ac.jp059-231-5017

Outcome results